2,908 followers
RT @ClinRheumatol: Long-term use of stable dose TNF-α inhibitor did not deteriorate atherogenic lipid profile in axial #Spondyloarthritis…
RT @ClinRheumatol: Long-term use of stable dose TNF-α inhibitor did not deteriorate atherogenic lipid profile in axial #Spondyloarthritis…
RT @ClinRheumatol: Long-term use of stable dose TNF-α inhibitor did not deteriorate atherogenic lipid profile in axial #Spondyloarthritis…
RT @ClinRheumatol: Long-term use of stable dose TNF-α inhibitor did not deteriorate atherogenic lipid profile in axial #Spondyloarthritis…
RT @ClinRheumatol: Long-term use of stable dose TNF-α inhibitor did not deteriorate atherogenic lipid profile in axial #Spondyloarthritis…